China Drug Applications Under Review Following Corruption Charges
Nature Biotechnology 2007 March; 25(3): 270
Showing items related by title, author, creator and subject.
A Bill to Amend the Federal Food, Drug, and Cosmetic Act to Provide That Drugs Will Be Regulated Under the Act Solely to Assure Their Safety, to Promote the Efficient and Fair Treatment of New Drug Applications, and for Other Purposes. H.R. 11446, 95th Congress, 2d Session Unknown author (United States. Congress. House, 1978-03-09)
Evidence b(i)ased Medicine -- Selective Reporting From Studies Sponsored by Pharmaceutical Industry: Review of Studies in New Drug Applications Melander, Hans; Ahlqvist-Rastad, Jane; Meijer, Gertie; Beermann, Bjorn (2003-05-31)OBJECTIVES: To investigate the relative impact on publication bias caused by multiple publication, selective publication, and selective reporting in studies sponsored by pharmaceutical companies. DESIGN: 42 placebo controlled ...